[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![OzmosiHealth Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1055982930.png) Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2627 followers
Created: 2025-07-10 14:04:33 UTC

$AAPG China NMPA approves Ascentage Pharma's Lisaftoclax, a novel Bcl-2 inhibitor, marking a new era in CLL/SLL treatment.

More Info: $XBI $IBB $XPH $PPH

![](https://pbs.twimg.com/media/GvgGfP6akAUa5aT.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1943310378060099717/c:line.svg)

**Related Topics**
[new era](/topic/new-era)
[$pph](/topic/$pph)
[$xph](/topic/$xph)
[$ibb](/topic/$ibb)
[$xbi](/topic/$xbi)
[more info](/topic/more-info)
[marking](/topic/marking)
[china](/topic/china)

[Post Link](https://x.com/OzmosiHealth/status/1943310378060099717)